Harraden Circle Investments’s Psyence Biomedical Warrant PBMWW Stock Holding History

Harraden Circle Investments’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.9K	Sell	1,149,000 -1,000	-0.1%	-$29	﹤0.01%	225
2026 Q1	$20.9K	Hold	1,150,000	–	–	﹤0.01%	168
2025 Q4	$21.3K	Hold	1,150,000	–	–	﹤0.01%	171
2025 Q3	$29K	Hold	1,150,000	–	–	0.01%	140
2025 Q2	$23.3K	Hold	1,150,000	–	–	0.01%	112
2025 Q1	$19.4K	Hold	1,150,000	–	–	0.01%	106
2024 Q4	$16.6K	Buy	+1,150,000	New	+$15.3K	0.01%	95

Other funds holding PBMWW

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Harraden Circle Investments's PBMWW Position: Q2 2026 in Review

Harraden Circle Investments reduced its Psyence Biomedical Warrant (PBMWW) stake by 0.09% in Q2 2026, selling an estimated $29 and leaving 1,149,000 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #225.

Harraden Circle Investments first reported a position in PBMWW in Q4 2024 and has held it in 7 quarters since. The position peaked at $29K in Q3 2025. 18 funds tracked by Wall St. Rank hold PBMWW as of Q2 2026.

Harraden Circle Investments held 1,149,000 shares of Psyence Biomedical Warrant worth $27.9K as of Q2 2026.
Harraden Circle Investments sold 1,000 Psyence Biomedical Warrant shares in Q2 2026, an estimated $29.
Psyence Biomedical Warrant made up ﹤0.01% of Harraden Circle Investments's portfolio in Q2 2026, its #225 holding.
Harraden Circle Investments first reported a position in Psyence Biomedical Warrant in Q4 2024 and has held it in 7 quarters since.
Harraden Circle Investments's Psyence Biomedical Warrant position peaked at $29K in Q3 2025.
18 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q2 2026.

Based on Harraden Circle Investments's 13F filing for Q2 2026, filed 14 Aug 2026.